The page is the record's research on the issuer — no analyst, no rating, no view.

HIKMA PHARMACEUTICALS PLC (HIK) — research page

UK · uk-cm-kg/LSE/HIK · as of 2026-11-06

Identity and listing

The issuer is HIKMA PHARMACEUTICALS PLC, listed on the LSE Main Market under ticker HIK, ISIN GB00B0LCW083, LEI 549300BNS685UXH4JI75. Its security type is Corporate, its segment is STMM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.

fieldvaluesource · read date
nameHIKMA PHARMACEUTICALS PLCsource · 2026-11-06
exchangeLSE Main Marketsource · 2026-11-06
tickerHIKsource · 2026-11-06
ISINGB00B0LCW083source · 2026-11-06
LEI549300BNS685UXH4JI75source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentSTMMsource · 2026-11-06
sectorPharmaceuticals and Biotechnology [201030]source · 2026-11-06
jurisdictionEngland and Wales (Companies House jurisdiction field)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 139 filings across 86 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 3 days. The latest filing is dated 2026-11-05 and is of type financial_statement, 1 day before the record date of 2026-11-06. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days across 892 issuers. In the sector Pharmaceuticals and Biotechnology [201030] the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days across 51 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer13931
exchange median: LSE Main Market (892 issuers)2943
sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers)4264
datetypecategoryfiling
2026-11-05financial_statementTrading Statement
2026-10-21early_warningHolding(s) in Company
2026-10-20early_warningHolding(s) in Company
2026-10-12ch_capitalcapital cancellation shares — 2026-08-25
2026-10-06ch_capitalcapital return purchase own shares

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.

Orderability

For the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.

client categoryoutcome
elective professional clientACM-200
eligible counterpartyACM-200

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 12 research houses: Barclays, Berenberg, BNP Paribas, BofA, Citi, Deutsche Numis, Jefferies, JP Morgan, Panmure Liberum, Peel Hunt, RBC and Stifel.

research houseanalystsource · read date
BarclaysJames Gordonissuer page · 2026-11-12
BerenbergBeatrice Fairbairnissuer page · 2026-11-12
BNP ParibasVictor Flochissuer page · 2026-11-12
BofACharlie Haywoodissuer page · 2026-11-12
CitiGiang Nguyenissuer page · 2026-11-12
Deutsche NumisKane Slutzkinissuer page · 2026-11-12
JefferiesJames Vane-Tempestissuer page · 2026-11-12
JP MorganZain Ebrahimissuer page · 2026-11-12
Panmure LiberumSeb Jantetissuer page · 2026-11-12
Peel HuntMiles Dixonissuer page · 2026-11-12
RBCNatalia Websterissuer page · 2026-11-12
StifelChristian Glennieissuer page · 2026-11-12

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No issuer years are sealed. The market earliest sealed date is not on the record. The live record began on 2026-09-11. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.

Sources

11 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
10.2
https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/HIK (identity.isin)
10.3
https://find-and-update.company-information.service.gov.uk/company/05557934 (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://www.londonstockexchange.com/stock/HIK/hikma-pharmaceuticals-plc/company-page (identity.sector)
10.6
https://mcp.uk-cm-kg.ai/events/LSE/HIK (the disclosure lines)
10.7
https://marketsecurities.fca.org.uk/officiallist (the halt flag)
10.8
https://www.hikma.com/media/f1ppfora/hikma-ar24-financial-statements.pdf (the auditor)
10.9
https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
10.10
https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/ (coverage)
10.11
https://mcp.uk-cm-kg.ai/record/LSE/HIK (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00B0LCW083"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:25795a969b340f32.